HRT Financial’s Lemonade LMND Stock Holding History

HRT Financial’s Portfolio LMND Stock Details LMND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-34,200	Closed	-$2.43M	–	4319
2025 Q4	$2.43M	Buy	34,200 +26,100	+322%	+$1.75M	0.01%	1182
2025 Q3	$433K	Buy	+8,100	New	+$395K	﹤0.01%	1966
2022 Q1	–	Sell	-11,700	Closed	-$492K	–	3513
2021 Q4	$492K	Buy	+11,700	New	+$658K	﹤0.01%	1880

Other funds holding LMND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

HRT Financial's LMND Position: Q3 2025 in Review

HRT Financial sold out of Lemonade (LMND) in Q3 2025, closing a stake of 17,007 shares — an estimated $830K sold.

HRT Financial first reported a position in LMND in Q2 2021 and held it in 6 quarters. The position peaked at $3.52M in Q1 2022. 300 funds tracked by Wall St. Rank hold LMND as of Q3 2025.

HRT Financial reported no remaining Lemonade position as of Q3 2025 after selling out during the quarter.
HRT Financial sold 17,007 Lemonade shares in Q3 2025, an estimated $830K.
HRT Financial first reported a position in Lemonade in Q2 2021 and held it in 6 quarters.
HRT Financial's Lemonade position peaked at $3.52M in Q1 2022.
300 funds tracked by Wall St. Rank held Lemonade as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.